Figure 1 a: PET-CT showing recurrent metastatic lesions on 28 July 2021;b: pelvic MR examination on September 2021, CR assessed;c: pelvic MR examination on February 2023, CR assessed;d: pelvic MR examination on October 2023, CR assessed.